Jagpal N. Netta's most recent trade in InMed Pharmaceuticals Inc was a trade of 3,750 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc | Jagpal N. Netta | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 3,750 | 6,250 | - | - | Employee Stock Option (Right to Buy) |